The Q2 FY25 earnings season has presented a mix of strong and challenging results across sectors, including banking, pharmaceuticals, energy, and infrastructure. Here’s a deeper look at key stocks to watch following their quarterly announcements.
ICICI Bank
ICICI Bank posted a 14.5% increase in net profit, rising to ₹11,746 crore from ₹10,261 crore, driven by a 9.5% growth in net interest income (NII) to ₹20,048 crore. Improved asset quality metrics, with Gross NPA falling to 1.97% from 2.15% (QoQ) and Net NPA down to 0.42% from 0.43% (QoQ), highlight ICICI’s effective risk management and steady operational growth in the banking sector.
Coal India
Coal India reported a 22% decline in profit to ₹6,274.8 crore from ₹8,048.6 crore and a 6.4% revenue dip to ₹30,673 crore. EBITDA fell by 14.2% to ₹8,617.1 crore, with a margin contraction of 250 basis points to 28.1%. Despite these challenges, Coal India announced an interim dividend of ₹15.75 per share for FY25, signaling confidence in cash flow and shareholder returns.
Bank of Baroda
With a 23% profit jump to ₹5,238 crore from ₹4,253 crore, Bank of Baroda showed solid growth in Q2. The bank’s NII rose by 7.3% to ₹11,622 crore, and improvements in asset quality were evident as Gross NPA fell to 2.50% from 2.88% (QoQ), with Net NPA declining to 0.60% from 0.69% (QoQ).
InterGlobe Aviation (IndiGo)
IndiGo reversed last year’s profit with a net loss of ₹986.7 crore, impacted by higher operational costs, though revenue grew 13.6% to ₹16,969.6 crore. EBITDA fell 0.5% to ₹2,434 crore, with the EBITDAR margin contracting 210 basis points to 14.3%. The board approved an investment of up to ₹295 crore in IndiGo Ventures Fund – I, indicating strategic expansion plans.
Bandhan Bank
Bandhan Bank reported a 30% increase in profit to ₹937 crore from ₹721 crore, supported by NII growth of 21% to ₹2,948 crore. The bank’s net interest margin expanded to 7.4% from 7.2%. However, the Gross NPA rose to 4.68% from 4.23% (QoQ), and Net NPA increased to 1.29% from 1.15% (QoQ), raising concerns about asset quality.
Macrotech Developers (Lodha)
Macrotech Developers delivered a strong Q2, with profit spiking 108.6% to ₹423.1 crore and revenue up 50.1% to ₹2,625.7 crore. This performance reflects demand growth in the real estate sector.
DLF
DLF recorded a 122.1% profit surge to ₹1,381.2 crore, driven by revenue growth of 46.5% to ₹1,975 crore. A tax write-back of ₹466.80 crore contributed to the impressive profit, highlighting the company’s strong standing in premium real estate.
Torrent Pharmaceuticals
With a 17.4% increase in profit to ₹453 crore and revenue growth of 8.6% to ₹2,889 crore, Torrent Pharmaceuticals continues to show resilience in the pharmaceutical sector.
Shriram Finance
Shriram Finance posted an 18.3% profit growth to ₹2,071.3 crore, alongside a 16.4% rise in NII to ₹5,606.7 crore. The company declared an interim dividend of ₹22 per share and announced a 1:5 stock split, indicating strong shareholder returns and liquidity-enhancing measures.
Phoenix Mills
Phoenix Mills’ profit dipped 4.3% to ₹292.2 crore, although revenue saw a modest increase of 5% to ₹918 crore. Despite a slight decline, the company’s stable revenue base shows ongoing demand in commercial real estate.
CMS Info Systems
CMS Info Systems recorded a 7.8% profit growth to ₹90.9 crore, with revenue up 15% to ₹624.5 crore. The cash management services provider remains a steady performer in its niche.
Gensol Engineering
Gensol Engineering posted a 29.5% profit increase to ₹22.9 crore, with revenue up 13.8% to ₹346.5 crore and EBITDA growing 123.5% to ₹106.6 crore. The company’s EBITDA margin expanded 1,510 basis points to 30.8%, showcasing operational efficiency in engineering services.
Yes Bank
Yes Bank’s Q2 results showed a 145.6% profit jump to ₹553 crore, supported by a 14.3% increase in NII to ₹2,200 crore. Improved asset quality, with Gross NPA falling to 1.6% (QoQ), underscores its progress in the private banking space.
These companies’ Q2 results highlight diverse challenges and opportunities across sectors. From banks showcasing asset quality improvements to real estate and pharma companies experiencing strong revenue growth, these stocks are positioned for close monitoring in the market.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor for investment decisions.
